EDMONTON, Nov. 3 /CNW/ - (ISA:TSX): Isotechnika Inc. today announced Dr.
Mariella Goggins, a principal investigator from the Company's recently
completed Phase 2b kidney transplant trial (PROMISE), has been selected to
present at the American Society of Nephrology conference to be held in
Philadelphia, PA, USA.
